Definition
The status of clinical trial acceptance for the person with cancer, as represented by a code.
Components
Data Element (this item)
-
Data Element ConceptPerson with cancer—clinical trial entry status
-
Object ClassPerson with cancer
-
PropertyClinical trial entry status
-
-
Value DomainClinical trial entry status code N
Representation
This representation is based on the value domain for this data element, more information is available at " Clinical trial entry status code N ".| Data Type | Number |
|---|---|
| Format | N |
| Maximum character length | 1 |
| Value | Meaning | Start Date | End Date | |
|---|---|---|---|---|
| Permissible Values | 1 | Clinical trial entry not offered | ||
| 2 | Clinical trial entry offered and accepted | |||
| 3 | Clinical trial entry offered and declined | |||
| 4 | Clinical trial not available | |||
| Supplementary Values | 8 | Unknown whether clinical trial entry offered | ||
| 9 | Clinical trial entry offered but patient response not stated/inadequately described |
Comments
Guide for use:
Record the appropriate code number for clinical trial proposed or entered throughout the course of treatment for cancer.
If this data item is coded as 2 Clinical trial entry offered and accepted, Person with cancer—clinical trial identification, text [X(399)] must also be completed.Comments:
A measurement of the percentage of patients entering clinical trials may have implications for access to, and the provision of, cancer services.
The collection of specific treatment information is useful to evaluate patterns of care, the effectiveness of different treatment modalities, and treatment by patient outcome.References
Royal College of Physicians of London 1999. Lung cancer: a core data set. London: Royal College of Physicians of London
Stedman TL 2006. Stedman's Medical Dictionary. 28th edition. Maryland: Lippincott Williams & WilkinsThis content Based on Australian Institute of Health and Welfare material. Attribution provided as required under the AIHW CC-BY licence.